medigraphic.com

2008, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2008; 46 (3)

Prevalence of Buccal Lesions on Type 2 Diabetes Mellitus

González-Guevara MB, Linares-Vieyra C, Rodríguez-de Mendoza LE

Language: Spanish
References: 34
Page: 237-245
PDF size: 157.95 Kb.


ABSTRACT

Objective: to know the prevalence of buccal lesions on type 2 diabetes mellitus patients and its association with blood glycemia levels.
Methods: descriptive cross-sectional study. Casual glycemia was practiced to 162 patients, who regularly attend public health services, and results from fasting blood glucose test were analyzed. A buccal examination and World Health Organization’s community periodontal index and treatment needs (CPITN) was practiced. Descriptive statistics and bivaried analysis were used.
Results: the woman:man relation was 3:1, age range from 17 to 80 years. Out of 99 patients with laboratory glycemia, 76 % was poorly controlled; 99 % showed at least one buccal lesion: 93.2 %, periodontal disease; 73.4 %, xerostomia and 28.4 %, erythematous candidiasis. Having bad controlled glucose, a group with xerostomia and erythematous candidiasis and another showed xerostomia plus erythematous candidiasis plus periodontal disease (OR = 3.5 and a value of p = 0.01).
Conclusions: presence of oral diseases is exhibited on patients with a poor glucose control. Medical attention results inefficient and insufficient and patients do not get orientation to understand their illness.


REFERENCES

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:S5-S10.

  2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.

  3. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, Morelos, México. México: Instituto Nacional de Salud Pública; 2003.

  4. Secretaría de Salud. Modificación a la norma oficial mexicana NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes mellitus en la atención primaria, para quedar como norma oficial mexicana NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes. Disponible en http://www.sakyd. gob.mx/unidades/cdi/nom/mo15ssa24.html

  5. Aguilar-Salinas CA, Velásquez-Monroy O, Gómez-Pérez FJ, González-Chávez A, Lara- Ezqueda A, Molina-Cuevas V, et al. Characteristic of patients with type 2 diabetes in México. Diabetes Care 2003; 26:2021-26.

  6. González-Villalpando ME, González-Villalpando G. Retinopatía diabética. En: Islas-Andrade S, Revilla- Monsalve C, editores. Diabetes mellitus. Tercera edición. México: McGraw-Hill Interamericana; 2005. p. 309-329.

  7. Escobedo-de la Peña J, Rico-Verdín B. Incidencia y letalidad de las complicaciones agudas y crónicas de la diabetes mellitus en México. Salud Publica Mex 1996;38:236-242.

  8. Sánchez-Chibrás JE, Islas-Andrade S. Pie diabético. En: Islas-Andrade S, Revilla-Monsalve C, editores. Diabetes mellitus. Tercera edición. México: McGraw-Hill Interamericana; 2005. p. 360-378.

  9. Little WJ, Falace AD, Miller SC, Rhodus LN. Dental management of the medically compromised patient. Fifth edition. St Louis, Missouri: Mosby; 1997. p. 387-409.

  10. Cotran RS, Kumar V, Collins T. Robbins patología estructural y funcional. Sexta edición. México: McGraw-Hill; 2000. p. 951-969.

  11. Gibson J, Lamey PJ, Lewis MAO, Frier BM. Oral manifestations of previously undiagnosed noninsulin dependent diabetes mellitus. J Oral Pathol Med 1990;19:284-87.

  12. Del Toro-Ávalos R, Aldrete-Rodríguez MG, Cruz-González A, Ramírez-Anguiano VM, Mendoza-Roaf PL, Vásquez-Castellanos JL, et al. Manifestaciones orales en pacientes diabéticos tipo 2 y no diabéticos. Invest Salud 2004;3:165-169.

  13. Obradovic B, Arambasin AC. Oral manifestations in diabetes. Acta Stomatol Croat 1991;25:59-63.

  14. Sandberg GE, Sundberg HE, Fjellstrom CA, Wikbland KF. Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract 2000;50:27-34.

  15. Vitkov L, Weitgasser R, Lungstein A, Noack MJ, Fuchs K, Krautgartner WD. Glycaemic disorders in denture stomatitits. J Oral Pathol Med 1999;28: 406-409.

  16. Sreebny LM, Yu A, Green A, Valdini A. Xerostomía in diabetes mellitus. Diabetes Care 1992;15:900-904.

  17. Aly FZ, Blackwell CC, Mackenzie DAC, Weir DM, Clarke BF. Factors influencing oral carriage of yeasts among individuals with diabetes mellitus. Epidemiol Infect 1992;109: 507-518.

  18. Molina-de Soschin D, Ramos-Monroy R, Arenas R, Fernández RF, Priego-Rubalcaba J, San Miguel- Fabián MG. Frecuencia de candidiasis oral en pacientes diabéticos tipo 2 ambulatorios en el Hospital General “Manuel Gea González”. Estudio clínico micológico. Dermatol Rev Mex 2002;46:3-9.

  19. Collin-Hanna L, Uusitupa M, Niskanen L, Kontturi-Närhi V, Markkanen H, Koivisto-Anna M, et al. Periodontol findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998;69:962-966.

  20. Ellis LG, Auclair PL. Tumors of the salivary glands atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology; 1995. p. 403-407.

  21. Albrecht M, Bánóczy J, Dinya E, Támas Gy Jr. Ocurrence of oral leukoplakia and lichen planus in diabetes mellitus. J Oral Pathol Med 1992;21: 364-366.

  22. American Diabetes Association. Standards of medical in diabetes. Diabetes Care 2005;28:S1-S36.

  23. Roed-Petersoen, Renstrup GA. Topographical classification of the oral mucosa suitable for electronic data processing. Its application to leukoplakias. Acta Odontol Scand 1969;27:681.

  24. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J. Development of the World Health Organization (WHO) Community Periodontal Index of Treatment Needs (CPITN). Int Dent J 1982;32:281-291.

  25. INEGI/Secretaría de Salud/Conapo. Proyecciones de la Población de México, 2000-2050. México: INEGI/Secretaría de Salud/Conapo; 2002.

  26. Indicadores socioeconómicos de la marginación: media nacional y estados con mayor índice. Disponible en http://www.unidad094.upn.mx/pyic/contexto/datos2.html

  27. Castro-Martínez MG, Herrera-Cornejo M. Neuropatía diabética. En: Diabetes mellitus. Tercera edición. México: McGraw-Hill Interamericana; 2005:348-359.

  28. Fernández LM. Diabetes e hipertensión. En: Gómez-Pérez FJ, Aguilar-Salinas CA. Diabetes actualidades terapéuticas. México: McGraw-Hill Interamericana; 2004. p. 89-100.

  29. Márquez-Corona ML, Heredia-Ponce E, Pontigo- Loyola PA, Islas-Márquez A. Enfermedad periodontal, caries radicular y flujo salival en diabéticos tipo II. Libro de resúmenes del XI Congreso de Investigación en Salud Pública. México: INSP; 2005. p. 259-260.

  30. Almas K, Al-Qahtani M, Al-Yami M, Khan N. The relationship between periodontal disease and blood glucose level among type II diabetic patients. J Contemp Dent Prac 2001;2:18-25.

  31. Tomita NE, Chinellato LE, Pernambuco RA, Lauris JR, Franco LJ. Periodontal conditions and diabetes mellitus in the Japanese-Brazilian population. Rev Saude Publica 2002;36:607-13.

  32. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Comm Dent Oral Epidemiol 2002;30:182-192.

  33. Katz J. Elevated blood glucose levels in patients with severe periodontal disease. J Clin Periodontol 2001;28:710-712.

  34. Batsakis JG. Tumours of head and neck. Clinical and pathological considerations. Second edition. Williams and Wilkins; 1984. p. 100-120.




2020     |     www.medigraphic.com